InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Fleming Alison B, Chief Technology Officer. Director active across 2 companies, notably COLLEGIUM PHARMACEUTICAL, INC. In total, 2 filings have been recorded. The latest transaction was disclosed on 10 August 2021 (Retenue fiscale). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
1,386 shares@ €16.23260.0015% mcap100.0% of flowCommon StockSEC:0001192482-21-000662
1,386 shares@ €16.23260.0015% mcap50.0% of flowCommon StockSEC:0001192482-21-000662:0
2 of 2 declarations
About Fleming Alison B
Alison B. Fleming is the EVP and Chief Technical Officer at Collegium Pharmaceutical, Inc. She oversees technical development and innovation within the company. Her expertise is essential for research and development of new products.
